Recruiting NCT05325580
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Magnesium sulfate.
- Who it may be relevant to
- Registry conditions: Head Pain. Basic parameters: 18 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Tunisia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Intravenous Magnesium Sulfate Vs Placebo to Treat Non-traumatic Acute Headaches in the Emergency Department
Overview
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Detailed description
Rate of Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Interventions
- Drug Magnesium sulfate
magnesium group 1g paracetamol + 20 min infusion of 2 g magnesium in 150 ml of saline serum and Placebo Group 1g paracetamol + 20 min infusion of 150 ml of saline serum
Primary outcome measures
- Intravenous Magnesium Sulfate to Treat Non -Traumatic Acute Headaches in the Emergency Department [Time frame: 1day]
Secondary outcome measures (1)
- Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department [Time frame: 1 day]
Eligibility criteria
Inclusion criteria
- informed consent
- age >18 years
- Acute non-traumatic acute headaches
- patients treated in ED
- Magnesium sulfate and aspirin administered intravenously (IV)
Exclusion criteria
- Current regular use of analgesics, anticonvulsants or antidepressants
- Renal disorder with a low glomerular filtration rate (<60 ml/min)
- Neuromuscular disorder
- Pregnant woman
- Contrindication
- Allergy to NSAID
- Traumatic Headache
- Chronic headache ( headache occurring at least 15 days per month for at least 3 months)
- Hemodynamic instability
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
Tunisia · 1 center
- University of Monasrtir — Monastir
Identifiers
NCT: NCT05325580 · Emergency Monastir